α-Ketoglutarate is a key biomolecule involved in
a number
of metabolic pathwaysmost notably the TCA cycle. Abnormal
α-ketoglutarate metabolism has also been linked with cancer.
Here, isotopic labeling was employed to synthesize [1-13C,5-12C,D4]α-ketoglutarate with the future
goal of utilizing its [1-13C]-hyperpolarized state for
real-time metabolic imaging of α-ketoglutarate analytes and
its downstream metabolites in vivo. The signal amplification
by reversible exchange in shield enables alignment transfer to heteronuclei
(SABRE-SHEATH) hyperpolarization technique was used to create 9.7%
[1-13C] polarization in 1 minute in this isotopologue.
The efficient 13C hyperpolarization, which utilizes parahydrogen
as the source of nuclear spin order, is also supported by favorable
relaxation dynamics at 0.4 μT field (the optimal polarization
transfer field): the exponential 13C polarization buildup
constant T
b is 11.0 ± 0.4 s whereas
the 13C polarization decay constant T
1 is 18.5 ± 0.7 s. An even higher 13C polarization
value of 17.3% was achieved using natural-abundance α-ketoglutarate
disodium salt, with overall similar relaxation dynamics at 0.4 μT
field, indicating that substrate deuteration leads only to a slight
increase (∼1.2-fold) in the relaxation rates for 13C nuclei separated by three chemical bonds. Instead, the gain in
polarization (natural abundance versus [1-13C]-labeled)
is rationalized through the smaller heat capacity of the “spin
bath” comprising available 13C spins that must be
hyperpolarized by the same number of parahydrogen present in each
sample, in line with previous 15N SABRE-SHEATH studies.
Remarkably, the C-2 carbon was not hyperpolarized in both α-ketoglutarate
isotopologues studied; this observation is in sharp contrast with
previously reported SABRE-SHEATH pyruvate studies, indicating that
the catalyst-binding dynamics of C-2 in α-ketoglutarate differ
from that in pyruvate. We also demonstrate that 13C spectroscopic
characterization of α-ketoglutarate and pyruvate analytes can
be performed at natural 13C abundance with an estimated
detection limit of 80 micromolar concentration × *%P
13C. All in all, the fundamental studies reported here
enable a wide range of research communities with a new hyperpolarized
contrast agent potentially useful for metabolic imaging of brain function,
cancer, and other metabolically challenging diseases.